155 related articles for article (PubMed ID: 37394831)
1. Prognostic significance of N6-methyladenosine-modified related chemotransferase METTL3 in gastric carcinoma: Evidence from meta-analysis.
Zhu C; Wu Q; Xu Y; Ma J; Hu Y; Wang J; Gao Z; Da M
Int J Biol Markers; 2023 Dec; 38(3-4):185-193. PubMed ID: 37394831
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
Liu GM; Zeng HD; Zhang CY; Xu JW
Dig Dis Sci; 2021 Apr; 66(4):1110-1126. PubMed ID: 32333311
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.
Ke L; Li S; Cui H
BMC Cancer; 2022 Nov; 22(1):1185. PubMed ID: 36397030
[TBL] [Abstract][Full Text] [Related]
6. A systematic review verified by bioinformatic analysis based on TCGA reveals week prognosis power of CAIX in renal cancer.
Zhang Z; Wu B; Shao Y; Chen Y; Wang D
PLoS One; 2022; 17(12):e0278556. PubMed ID: 36542612
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis.
Xian F; Ren D; Bie J; Xu G
Front Immunol; 2023; 14():1119168. PubMed ID: 37138876
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and Meta-Analysis.
Liu K; Gao Y; Gan K; Wu Y; Xu B; Zhang L; Chen M
Cancer Control; 2021; 28():1073274821997455. PubMed ID: 33631954
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis.
Liu W; Hu K; Zhang F; Lu S; Chen R; Ren Z; Yin X
Int J Biol Markers; 2021 Jun; 36(2):17246008211032689. PubMed ID: 34374576
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
Chen X; Liang R; Lai L; Chen K; Zhu X
Front Oncol; 2021; 11():697369. PubMed ID: 34490092
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis.
Zhang D; Liu Z; Yin X; Qi X; Lu B; Liu Y; Hou J
Int J Biol Markers; 2018 Aug; 33(3):266-274. PubMed ID: 29658364
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological value of m6A regulators in human cancers: a meta-analysis.
Su Z; Xu L; Dai X; Zhu M; Chen X; Li Y; Li J; Ge R; Cheng B; Wang Y
Aging (Albany NY); 2022 Nov; 14(21):8818-8838. PubMed ID: 36347025
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
Zhang Y; Yang X
Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
[TBL] [Abstract][Full Text] [Related]
14. High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis.
Liu W; Zhang Y; Wang M; Wang M; Yang Q
Front Oncol; 2023; 13():1229349. PubMed ID: 38023187
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.
Liu JL; Gao W; Kang QM; Zhang XJ; Yang SG
PLoS One; 2013; 8(8):e71930. PubMed ID: 23936532
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis.
Hong X; Wang G; Xu G; Shi W; Wang T; Rong Z; Mo C
Medicine (Baltimore); 2022 Jan; 101(3):e28507. PubMed ID: 35060503
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression.
Agboyibor C; Dong J; Effah CY; Drokow EK; Pervaiz W; Li D; Kang L; Ma X; Li J; Liu Z; Liu HM
Cancer Control; 2021; 28():10732748211051557. PubMed ID: 34802287
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis.
Ji K; Zhang L; Zhang M; Chu Q; Li X; Wang W
Medicine (Baltimore); 2016 Feb; 95(5):e2641. PubMed ID: 26844481
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]